Investing.com -- EssilorLuxottica (EPA: ESLX) received an upgrade to a "buy" rating from analysts at Jefferies, reflecting ...

EssilorLuxottica acquires the Canadian med-tech start-up Cellview The company’s ultra-widefield proprietary technology allows for fast and easy high-quality images, providing a comprehensive view of ...

In a report released today, Piral Dadhania from RBC Capital maintained a Buy rating on EssilorLuxottica SA (0OMK – Research Report), with a ...

Jefferies upgraded EssilorLuxottica (ESLOY) to Buy from Hold with a price target of EUR 310, up from EUR 195. The company is a “structural ...

The agreement allows the group to expand its portfolio of ophthalmic instruments and solutions, further strengthening its ...

Jefferies analyst Julien Dormois upgraded EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), a $130 billion market cap leader in ...

Shares of EssilorLuxottica (EPA:EL) climbed 1.5% following the company's announcement of its acquisition of Cellview Imaging, ...

Read here for an analysis of EssilorLuxottica's market leadership, growth potential, and future value drivers, with a BUY ...

According to a 3 February press release, EssilorLuxottica received simultaneous clearance from the US Food and Drug ...

Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA: ESLX) to "outperform," citing strong fundamentals ...

EssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...